SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-114399
Filing Date
2020-04-22
Accepted
2020-04-22 09:00:40
Documents
12
Period of Report
2020-04-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d921204d8k.htm   iXBRL 8-K 23836
  Complete submission text file 0001193125-20-114399.txt   141961

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20200417.xsd EX-101.SCH 3058
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20200417_lab.xml EX-101.LAB 17374
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20200417_pre.xml EX-101.PRE 10945
14 EXTRACTED XBRL INSTANCE DOCUMENT d921204d8k_htm.xml XML 3277
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 20806763
SIC: 2834 Pharmaceutical Preparations